1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Impact on follow-up strategies in patients with primary sclerosing cholangitis
(
- Contribution to journal › Article
- 2022
-
Mark
Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma
(
- Contribution to journal › Article
- 2021
-
Mark
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers
(
- Contribution to journal › Article
- 2019
-
Mark
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis
(
- Contribution to journal › Article
- 2018
-
Mark
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
(
- Contribution to journal › Article
- 2017
-
Mark
Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis
(
- Contribution to journal › Article
-
Mark
Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis
(
- Contribution to journal › Article
-
Mark
Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans
(
- Contribution to journal › Article
-
Mark
Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma : A nested case-control study
(
- Contribution to journal › Article